ARTICLE | Company News
Hybrigenics, XTL deal
September 11, 2000 7:00 AM UTC
The companies will develop therapeutics to treat hepatitis C virus (HCV) infection. Hybrigenics will use its PIMRider proteomics and bioinformatics platform to identify protein domains involved in pro...